Nasal Microbiome and Allergic Rhinitis in Children: Insights on Diversity and Symptom Correlation
Introduction
Table of Contents
The human microbiome refers to the collection of microorganisms in the human body. In recent years, research has focused on the role of the microbiome in health and diseases, particularly allergic rhinitis (AR). The nasal mucosa is home to many microbes that contribute to health and can influence inflammation and allergic responses.
Allergic rhinitis is an inflammatory nasal condition triggered by specific allergens. It involves immune responses that cause symptoms such as sneezing, nasal congestion, and itchy eyes. Studies suggest that the nasal microbiome impacts the immune response related to AR.
Objectives of the Study
This study uses advanced sequencing methods to compare the nasal microbiota between children with AR and healthy controls. It aims to explore how microbiome characteristics relate to AR severity.
Materials and Methods
Participants
The study included 45 children diagnosed with perennial AR and 40 healthy controls. Diagnosis was based on symptoms and specific tests for allergens. This study received ethical approval, and informed consent was obtained from guardians.
Sample Collection
Nasal swabs were collected to analyze the microbiome. Samples were processed using standard laboratory techniques to extract DNA for sequencing.
Analysis
The V3 and V4 regions of the 16S rRNA gene were amplified. Sequences were analyzed using bioinformatics tools to determine the diversity and composition of the microbiomes in both groups.
Results
Clinical Characteristics
The two groups showed no significant differences in age, gender, or BMI.
Microbial Diversity
Alpha diversity indices showed higher richness and evenness in AR patients compared to healthy controls. Although overall richness did not differ, certain diversity indices indicated a distinct change in the nasal microbiome composition of AR patients.
Microbial Composition
At the phylum level, Firmicutes, Proteobacteria, and Actinobacteria were predominant. Notably, Staphylococcus was more abundant in AR patients, suggesting its role in AR pathophysiology. In contrast, Moraxella was more common in healthy participants.
Correlations with Symptoms
Analysis showed that nasal microbiome composition correlates with the severity of AR symptoms, particularly in comparing mild and moderate-to-severe AR patients.
Discussion
This study reveals important differences in the nasal microbiome between AR patients and healthy individuals. Higher Staphylococcus abundance may contribute to inflammation in AR. The study underscores the significance of the nasal microbiome in allergic responses and points to potential targets for therapy.
Further research is necessary to establish causal relationships and explore how environmental factors may affect the nasal microbiome and AR severity.
Conclusion
The study highlights the unique characteristics of the nasal microbiome in children with AR. The prominence of Staphylococcus indicates it may be a biomarker for AR. Overall, understanding these microbiome relationships can aid in developing new treatment approaches for AR in children.